Two ICREA spin offs obtain funding from H2020 SME support instrument. The entrepreneurs Laura Soucek (ICREA at VHIO) and Roger Gomis (ICREA at IRB) have both secured a bunch of money from H2020 SME instrument this week. Their two companies are attacking different aspects of cancer tumors. Inbiomotion, Roger’s company is testing a platform to prevent breast cancer from invading bone marrow. Peptomyc, Laura’s company, has invented an innovative mollecule that blocks one of the most critical oncogenes, applicable to a wide array of different tumors.
Congratulations Laura and Roger, and keep up the good work!
More details? Click here.
OTHER NEWS
ICREA call 2025 is open
Each year ICREA opens a call for permanent positions in the Catalan research system for senior researchers. The selected researchers…
ERC Consolidator grants 2024
Congratulations to César Rodriguez-Emmenegger and Arnau Sebé-Pedrós for this great achievement! · César Rodriguez-Emmenegger's (IBEC) project carries the title 'PhagoSynCell…